Table IV.
Outcome parameters in patients randomized to dexmedetomidine-fentanyl or propofol-fentanyl.
| Outcome parameter | DF group (n=50) | PF group (n=50) | P-value |
|---|---|---|---|
| No. of times additional lidocaine was required | 0.802 | ||
| 0 | 22 | 20 | |
| 1 | 13 | 16 | |
| >2 | 15 | 14 | |
| MOAA/S score 5/4/3/2/1/0 | |||
| T2 | 0/5/10/35/0/0 | 0/7/6/37/0/0 | 0.499 |
| T4 | 15/24/6/5/0/0 | 12/23/8/7/0/0 | 0.808 |
| Recovery time, min | 13.1±1.68a | 11.91±2.14 | 0.002 |
Values are presented as mean ± standard deviation, or number of patients. The MOAA/S scale ranges from 5 (alert) to 0 (asleep). MOAA/S, Modified Observer's Assessment of Alertness/Sedation; DF group, dexmedetomidine-fentanyl group; PF group, propofol-fentanyl group.
a
P<0.05 vs. the PF group.